Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2/3 1Phase 2 1Phase 1 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Classical hematology 77Thoracic 7Gastrointestinal 7CNS 6Plasma cell 5Genitourinary 4Myeloid 3Gynecologic 3Sarcoma 2Other hematologic neoplasm 2Lymphoid 2Head & Neck 2Other 1Breast 1

Conditions

Prostatic Neoplasms 5024Carcinoma, Renal Cell 1577Urinary Bladder Neoplasms 1279Kidney Neoplasms 724Breast Neoplasms 643Neoplasms 630Carcinoma, Transitional Cell 490Carcinoma, Non-Small-Cell Lung 469Neoplasm Metastasis 468Melanoma 422Ovarian Neoplasms 401Colorectal Neoplasms 373Lung Neoplasms 333Pancreatic Neoplasms 262Sarcoma 233Stomach Neoplasms 227Uterine Cervical Neoplasms 225Testicular Neoplasms 216Non-Muscle Invasive Bladder Neoplasms 215Head and Neck Neoplasms 192Squamous Cell Carcinoma of Head and Neck 189Colonic Neoplasms 167Carcinoma, Hepatocellular 167Esophageal Neoplasms 165Endometrial Neoplasms 165Wilms Tumor 159Recurrence 131Triple Negative Breast Neoplasms 130Small Cell Lung Carcinoma 127Neuroblastoma 127

Interventions

Rivaroxaban 1Gemcitabine 1Aspirin 1ALT-836 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × Venous Thromboembolism × Genitourinary × Clear all
NCT06866964 2026-02-02

ASPIRE

Wake Forest University Health Sciences

Phase 2 Recruiting
35 enrolled
Classical hematologyGenitourinary

Neoplasms, Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Venous Thromboembolism

NCT05920343 2025-07-10

PREVENT-GU

Ottawa Hospital Research Institute

Phase 2/3 Recruiting
120 enrolled
Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT03006562 2020-08-05

PREVENTER

Johns Hopkins University

Phase 4 Terminated
501 enrolled 13 charts
Classical hematologyGenitourinary

Prostatic Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT01325558 2016-07-15

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Altor BioScience

Phase 1 Completed
30 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡